“A Phase I Double Blind, Placebo-Controlled, Randomized Study Of The Safety And Immunogenicity Of An Adjuvanted Hiv-1 Gag-Pol-Nef Fusion Protein And Adenovirus 35 Gag-Rt-Int-Nef Vaccine In Healthy Hiv-Uninfected African Adults”. Plos One 10. Plos One: e0125954. http://www.ncbi.nlm.nih.gov/pubmed/25961283.
. 2015. “Assessment Of Viral Inhibition Activity In Low Seroprevalent Adenovirus-35 Vectored Hiv Vaccines +/- Adjuvanted Protein Or Electroporated Dna”. In Hiv Research For Prevention 2014: Aids Vaccine, Microbicide And Arv-Based Prevention Science (Hivr4P). Hiv Research For Prevention 2014: Aids Vaccine, Microbicide And Arv-Based Prevention Science (Hivr4P). Cape Town, SA. http://hivr4p.org/.
. 2014. “Safety, Adherence And Acceptability Of Intermittent Tenofovir/emtricitabine As Hiv Pre-Exposure Prophylaxis (Prep) Among Hiv-Uninfected Ugandan Volunteers Living In Hiv-Serodiscordant Relationships: A Randomized, Clinical Trial”. Plos One 8. Plos One: e74314. http://www.ncbi.nlm.nih.gov/pubmed/24086333.
. 2013. “A Cross-Sectional Study In Eastern And Southern Africa To Characterize Laboratory Reference Intervals In Healthy Adults For Hiv Prevention Trials”. In Aids Vaccine 2008 Conference. Aids Vaccine 2008 Conference. Cape Town, South Africa. http://www.vaccineenterprise.org/conference_archive/2008/index.html.
. 2008.